IBM shares are having a good Friday. The stock was up nearly 5% in premarket trading, sitting around $277.36, as investors continued to rotate into large-cap tech names. Nasdaq futures were up 0.22% and S&P 500 futures gained 0.19%, giving IBM some tailwind to extend its recent rebound after a choppy few months.
Part of the positive sentiment seems to be spilling over from Snowflake's strong earnings and its new agentic AI partnership with Amazon Web Services. There's also some broader market optimism around ongoing U.S.-Iran negotiations, which tends to boost risk appetite. So IBM is catching a nice wave.
Beyond the Market Noise: What IBM Is Actually Doing
IBM hasn't been sitting still. The company recently launched Project Lightwell with Red Hat, a $5 billion initiative to strengthen open-source software security using AI-powered vulnerability detection. They're putting a global team of more than 20,000 engineers on it, and it's already being tested by big financial institutions like Goldman Sachs, JPMorgan Chase, and Visa.
Separately, IBM announced plans to invest more than $10 billion in quantum computing over the next five years. The goal: deliver a large-scale fault-tolerant quantum computer by 2029. That's a long-term bet, but it's a big one, and it's part of IBM's effort to expand its global quantum ecosystem.
What the Charts Are Saying
Technically, IBM looks pretty good on the surface. It's trading 19.3% above its 20-day simple moving average (SMA) of $232.53, 16.4% above the 50-day SMA of $238.30, and 2.6% above the 200-day SMA of $270.18. So price-wise, it's well above all the key averages, which is generally a bullish sign.
But here's the catch: the moving averages themselves are still in a bad configuration. The 20-day SMA is below the 50-day SMA, and the 50-day SMA is below the 200-day SMA — that's the "death cross" that formed back in March. So while the stock price is strong right now, the underlying trend structure hasn't fully healed. For bulls, you'd want to see those averages start to turn up and eventually cross back into a bullish alignment. That takes time.
Momentum, at least, is improving. The MACD (moving average convergence divergence) is above its signal line, and the histogram is positive. In plain English, that means the downward pressure that was building is fading, and near-term momentum is turning positive.
Key levels to watch:
- Resistance: $319.50 — near a prior ceiling and the upper end of the 52-week range. Rallies have stalled here before.
- Support: $230.50 — a prior buyer-defense zone, closer to where the stock broke down in May.
Earnings Preview and Analyst Outlook
IBM is scheduled to report its next quarterly results on July 22, 2026. Here's what the Street is expecting:
- EPS estimate: 302 cents (up from 280 cents a year ago)
- Revenue estimate: $17.86 billion (up from $16.98 billion)
- Valuation: P/E of 23.4x — which is fairly reasonable for a company of IBM's stature
Analysts are mostly bullish. The consensus rating is Buy, with an average price target of $286.67. Recent moves include:
- RBC Capital: Outperform, lowered target to $300 (May 6)
- Wedbush: Outperform, maintained target at $320 (May 6)
- HSBC: Upgraded to Hold, raised target to $231 (April 28)
So the bulls are still in charge, though the stock is already trading near the average target.
Why ETF Holders Should Care
IBM is a big component in several dividend-focused ETFs. Here are the top ones:
- First Trust NASDAQ Technology Dividend Index Fund (TDIV): 6.97% weight
- FT Vest Technology Dividend Target Income ETF (TDVI): 8.42% weight
- Invesco Dow Jones Industrial Average Dividend ETF (DJD): 5.09% weight
Because IBM has such a heavy weight in these funds, any significant inflows or outflows for these ETFs will force automatic buying or selling of the stock. So if you're watching IBM, keep an eye on these ETFs — they can amplify moves.
Photo via Shutterstock
